A new study sheds more light on the effect of Covid-19 infection among children.
Category: pharma & healthcare
The Coronavirus Spurs Drug Repurposing Innovation
The Covid-19 crisis appears to have spawned renewed interest in repurposing of drugs. Scientists are canvassing extensive libraries of existing drug compounds in search of potential Covid-19 treatments.
Kidneys And Covid-19: Renal Manifestations Of The Novel Coronavirus
Covid-19 can damage many organs including the kidneys.
100,000 Dead And Countless Wounded
Yesterday marked a tragic milestone in our battle against Covid-19—more than 100,000 dead and an unknowable number of wounded.
Confronting Barriers To Covid-19 Vaccine Acceptance
To protect as many people as possible, especially the vulnerable, planning and education must begin now.
A Key Protein That Leads To Covid-19 Infection May Be Less Common In Children, Researchers Find
Can we conclude that such differences imply a difference in overall susceptibility to infection? Possibly, but not certainly.
A Nasty Trick In The Covid-19 Repertoire
This may be one of the first signs that a more transmissible and lethal strain of SARS-2 will emerge, one that accelerates the pandemic still further.
Remdesivir Revealed: What The Finally Released Data Tells Us
Early results generated a great deal of hype and a world wide stampede for the drug. But the release of the full data tells a different story.
It’s Too Early For The US Government To Place Risky, Billion Dollar Bets On Covid Vaccines
The US government is paying pharmaceutical companies with robust finances many hundreds of millions to do what is already in their best interest.
What Happens If We Can’t Find A Coronavirus Vaccine That Works?
If we acknowledge the reality that the vaccines currently being tested might fail or protect only some of us, what policy choices can our lawmakers and elected officials enact now that will ensure our protection no matter the outcome?
